COM:SILENCE-THERAPEUTICS
Silence Therapeutics
- Stock
Last Close
540.00
01/01 00:00
Volume Today
913.53K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | |||||||||
average payables | 290.50K - | 508K 74.87% | 373.50K 26.48% | 367.50K 1.61% | 495K 34.69% | 804.50K 62.53% | 1.47M 82.54% | 2.04M 38.75% | |
average receivables | |||||||||
book value per share | 0.63 - | 0.55 12.31% | 0.94 71.45% | 0.78 17.75% | 0.75 3.58% | 0.50 33.39% | 0.28 44.18% | 0.11 60.20% | |
capex per share | -0.00 - | -0.01 113.37% | -0.01 98.06% | -0.01 42.05% | -0.00 67.85% | -0.00 8.10% | -0.00 95.52% | -0.01 8,004.86% | |
capex to depreciation | -0.46 - | -1.02 119.11% | -4.67 358.74% | -1.73 62.91% | -0.40 76.94% | -0.47 17.93% | -0.02 96.04% | -1.86 9,835.31% | |
capex to operating cash flow | 0.02 - | 0.04 74.99% | 0.10 188.07% | 0.05 48.19% | 0.02 66.22% | 0.01 37.76% | -0.01 146.46% | -0.47 9,012.43% | |
capex to revenue | -1.18 - | -22.53 1,810.43% | -0.70 - | -10.81 1,450.40% | -0.04 - | -0.14 292.89% | |||
cash per share | 0.48 - | 0.43 8.85% | 0.81 87.05% | 0.56 31.06% | 0.62 10.16% | 0.38 38.70% | 0.45 18.20% | 0.46 2.65% | |
days of inventory on hand | |||||||||
days payables outstanding | 30.76 - | 22.19 27.88% | 10.62 52.13% | 221.70 - | |||||
days sales outstanding | |||||||||
debt to assets | 0.06 - | 0.07 14.92% | 0.02 73.13% | 0.03 58.85% | 0.05 67.39% | 0.10 103.91% | 0.55 454.56% | 0.89 63.79% | |
debt to equity | 0.06 - | 0.07 16.00% | 0.02 74.49% | 0.03 60.60% | 0.05 70.81% | 0.11 115.27% | 1.20 1,001.71% | 8.49 605.34% | |
dividend yield | |||||||||
earnings yield | -0.05 - | -0.05 7.30% | -0.03 52.80% | -0.03 16.50% | -0.01 80.87% | -0.06 1,031.89% | -0.06 0.46% | -0.08 22.99% | |
enterprise value | 165.97M - | 191.90M 15.62% | 213.15M 11.07% | 249.97M 17.27% | 246.82M 1.26% | 269.60M 9.23% | 297.80M 10.46% | 393.22M 32.04% | |
enterprise value over ebitda | -19.07 - | -16.48 13.59% | -23.05 39.91% | -24.87 7.88% | -74.19 198.33% | -13.40 81.94% | -13.32 0.55% | -11.05 17.08% | |
ev to operating cash flow | -24.57 - | -20.29 17.39% | -25.82 27.23% | -24.83 3.83% | -25.71 3.54% | -16.09 37.44% | 172.44 1,171.96% | 235.18 36.39% | |
ev to sales | 1.42K - | 12.79K 801.87% | 324.63 - | 15.43K 4,651.86% | 1.22K - | 71.77 94.12% | |||
free cash flow per share | -0.16 - | -0.19 23.76% | -0.14 26.78% | -0.15 6.81% | -0.14 8.02% | -0.24 72.52% | 0.02 109.49% | 0.01 53.05% | |
free cash flow yield | -0.04 - | -0.05 23.76% | -0.03 26.78% | -0.04 6.81% | -0.03 8.02% | -0.06 72.52% | 0.01 109.49% | 0.00 62.18% | |
graham net net | 0.44 - | 0.39 9.80% | 0.79 101.59% | 0.54 32.45% | 0.58 7.81% | 0.32 44.10% | 0.11 65.60% | -0.48 534.34% | |
graham number | 1.70 - | 1.65 3.00% | 1.48 10.04% | 1.45 2.11% | 0.62 57.05% | 1.71 174.58% | 1.28 25.45% | 1.00 22.04% | |
income quality | 0.75 - | 0.85 13.63% | 1.24 45.67% | 1.19 4.00% | 5.93 397.43% | 0.91 84.66% | -0.09 109.69% | -0.05 41.75% | |
intangibles to total assets | 0.27 - | 0.24 10.68% | 0.11 54.43% | 0.14 28.25% | 0.15 5.39% | 0.21 43.81% | 0.17 20.40% | 0.09 43.52% | |
interest coverage | -250.67 - | -692.03 - | -2.25K 225.36% | ||||||
interest debt per share | 0.00 - | 0.00 - | 0.00 2.49% | ||||||
inventory turnover | |||||||||
invested capital | 0.01 - | 0.04 174.24% | |||||||
market cap | 181.86M - | 208.76M 14.79% | 265.06M 26.97% | 288.98M 9.02% | 289.56M 0.20% | 291.10M 0.53% | 311.03M 6.85% | 420.33M 35.14% | |
net current asset value | 19.56M - | 20.22M 3.39% | 52.43M 159.29% | 40.40M 22.94% | 42.89M 6.16% | 25.67M 40.15% | 12.30M 52.09% | -513K 104.17% | |
net debt to ebitda | 1.83 - | 1.45 20.72% | 5.61 287.88% | 3.88 30.86% | 12.85 231.04% | 1.07 91.69% | 0.59 44.59% | 0.76 28.70% | |
net income per share | -0.20 - | -0.22 7.30% | -0.10 52.80% | -0.12 16.50% | -0.02 80.87% | -0.26 1,031.89% | -0.26 0.46% | -0.40 52.69% | |
operating cash flow per share | -0.15 - | -0.19 21.93% | -0.13 31.24% | -0.14 11.84% | -0.14 4.83% | -0.24 73.68% | 0.02 109.64% | 0.02 11.06% | |
payables turnover | 11.87 - | 16.45 38.65% | 34.37 108.90% | 1.65 - | |||||
receivables turnover | |||||||||
research and ddevelopement to revenue | 48.27 - | 592.27 1,126.90% | 11.31 - | 496.44 4,288.21% | 54.66 - | 3.69 93.25% | |||
return on tangible assets | -0.42 - | -0.49 16.70% | -0.12 75.22% | -0.18 45.09% | -0.03 80.38% | -0.60 1,640.53% | -0.51 14.88% | -0.42 18.10% | |
revenue per share | 0.00 - | 0.00 88.83% | 0.01 - | 0.00 97.93% | 0.00 - | 0.07 1,962.90% | |||
roe | -0.33 - | -0.40 22.37% | -0.11 72.47% | -0.16 41.65% | -0.03 80.16% | -0.53 1,599.28% | -0.94 78.32% | -3.59 283.63% | |
roic | 3.05 - | 2.47 18.78% | 0.16 93.67% | 0.37 137.06% | 0.05 85.96% | 3.51 6,633.78% | -1.13 132.31% | -1.13 0.27% | |
sales general and administrative to revenue | 30.26 - | 217.20 617.66% | 5.15 - | 404 7,745.65% | 39.52 - | 2.55 93.54% | |||
shareholders equity per share | 0.63 - | 0.55 12.31% | 0.94 71.45% | 0.78 17.75% | 0.75 3.58% | 0.50 33.39% | 0.28 44.18% | 0.11 60.20% | |
stock based compensation to revenue | 13.56 - | 75.13 454.26% | 0.62 - | 39.88 6,363.95% | 2.39 - | 0.49 79.37% | |||
tangible asset value | 19.78M - | 20.68M 4.57% | 53.76M 159.96% | 46.43M 13.63% | 44.29M 4.60% | 26.86M 39.35% | 13.18M 50.93% | 917K 93.04% | |
tangible book value per share | 0.45 - | 0.41 8.91% | 0.84 104.75% | 0.67 20.78% | 0.63 4.79% | 0.38 39.67% | 0.18 54.07% | 0.01 93.61% | |
working capital | 19.56M - | 20.22M 3.39% | 52.43M 159.29% | 40.40M 22.94% | 42.89M 6.16% | 25.67M 40.15% | 27.81M 8.35% | 50.82M 82.74% |
All numbers in GBP (except ratios and percentages)